Pediatric Heart Transplant Wait-List Mortality Has Declined Since 1999

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Aug. 7, 2024 -- Pediatric heart transplant (HT) wait-list mortality has declined, but the 2016 pediatric HT allocation policy revisions do not appear to be the reason, according to a study published in the Aug. 13 issue of the Journal of the American College of Cardiology.

Alyssa Power, M.D., from the Stanford University School of Medicine in Palo Alto, California, and colleagues examined whether 2016 United Network for Organ Sharing revisions of pediatric HT allocation policy were associated with reduced wait-list mortality. Children listed for HT from 1999 to 2023 were identified and grouped according to era (1999 to 2006 [era 1]; 2006 to 2016 [era 2]; 2016 to 2023 [era 3]).

The researchers found that across eras, wait-list mortality declined 8 percentage points (21, 17 and 13 percent, respectively). At listing, children were less sick in era 3 than era 1, with 6, 11, and 1 percentage points less extracorporeal membrane oxygenation use, ventilator use, and dialysis use, respectively. Ventricular assist device (VAD) use was 13 percentage points higher, and there was a 9 percentage point decrease in VAD mortality. The 2016 revisions were not associated with lower wait-list mortality in multivariable analyses, but they were associated with VAD use (in era 3), ABO-incompatible transplant, improved patient selection, and narrowing racial disparities.

"Wait-list mortality has declined, which is a very good thing, but based on our analysis, it doesn't look like the allocation changes made the difference," senior author Christopher S. Almond, M.D., M.P.H., also from the Stanford University School of Medicine, said in a statement.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords